I wonder how many long-term users of Ashwagandha there are, and how often people experience tolerance or withdrawal. Tolerance and withdrawal should be common if Ashwagandha is a GABA receptor agonist.

Posted 15 March 2012 - 03:28 AM
Posted 15 March 2012 - 04:20 AM
I wonder how many long-term users of Ashwagandha there are, and how often people experience tolerance or withdrawal. Tolerance and withdrawal should be common if Ashwagandha is a GABA receptor agonist.
Posted 15 March 2012 - 05:56 AM
Posted 15 March 2012 - 01:11 PM
Posted 16 March 2012 - 02:51 AM
Posted 16 March 2012 - 03:04 AM
I wonder how many long-term users of Ashwagandha there are, and how often people experience tolerance or withdrawal. Tolerance and withdrawal should be common if Ashwagandha is a GABA receptor agonist.
Ashwagandha is a GABA receptor agonist. The question is how strong is it really at the recommended dose.
Essentially, this study demonstrated a trend for the anxiolytic superiority of drug over placebo at week 2, and a statistically significant superiority at week 6. The advantage for Aswagandha was observed only with Hamilton Anxiety ratings, and with responder analyses, but not with global ratings; this may have bean because the latter had a narrower rating range, and were therefore less sensitive to clinical change. Aswagandha was well tolerated, with adverse effects being comparable to those observed with placebo. At 6 weeks, abrupt withdrawal did not appear to be associated with any withdrawal phenomena. Thus, Aswagandha appeared to have several of the advantages but none of the disadvantages of conventional anxiolytic drugs such as the benzodiazepines, the tricyclic antidepressants, and buspirone. This study therefore confirmed the preliminary observations of the unpublished open study of the experimental drug in patients with anxiety disorders (Manufacturer, data on file).
Benzodiazepines produce anxiolysis within days; antidepressant drugs and buspirone reduce anxiety in approximately a fortnight. Speed of response was regrettably not addressed in this study. However, it is likely that significant response will be obtained in most patients within the first fortnight of therapy itself, as Aswagandha was near-significantly superior to placebo at this time-point. Future studies need to address the magnitude of anxiolysis during the first week to ascertain the position of Aswagandha relative to conventional anxiolytic drugs.
What might be the mechanism of action of Aswagandha? As reviewed earlier, Aswagandha has been shown to have GABA- mimetic properties (Mehta et al.,1991; Kulkami et al.,1993); since GABA agonism has been linked to anxiolysis (Stah1,1998), it is conceivable that Aswagandha contains a constituent that alleviates anxiety by modulating GABA neurotransmission.
Posted 16 March 2012 - 03:13 AM
Posted 16 March 2012 - 03:45 AM
Posted 16 March 2012 - 04:00 AM
I think the GABA tolerance is real, but that is only one mechanism by which ashwagandha governs mood. For me, what I can identify as GABA like effects only last a short time--a special feeling of calmness, sometimes an odd feeling of smelling something burning as I am waking up in the morning. But ashwagandha also modulates the HPA axis, particularly lowering cortisol, and this may cause its long-term calming effect. It can also restore neural outgrowths that have been damaged during periods of stress.
At least three studies have examined the efficacy of ASW in anxiety disorders. In a preliminary investigation, the safety and efficacy of an ethanolic extract of ASW were examined in 50 patients with anxiety disorders. By the end of the first month of treatment, 36 patients showed moderate to excellent improvement at a dose of 1 g/day; in about half of these cases, these statistically significant benefits developed within the first 2 weeks, itself. These 36 patients were continued on ASW for up to 18 months, after which the medication was uneventfully withdrawn. ASW remained effective and was very well tolerated (data available from the author on request). [...]
Auddy et al. (2008) described a 2-month, double-blind, randomized controlled study which examined benefits with a standardized extract of ASW in 130 subjects who received a descriptive diagnosis of chronic stress in an Ayurvedic hospital. ASW was dosed at 125, 250, or 500 mg/day; a fourth group of patients received placebo. All doses of ASW attenuated modified HAM-A scores significantly more than did placebo at the 1-month follow-up; there was further improvement at the 2-month endpoint. The benefits with ASW appeared to be dose-dependent; placebo patients improved little. Furthermore, relative to placebo, ASW significantly lowered heart rate (by 6-8%), systolic blood pressure (by 2-3%), and diastolic blood pressure (by 5-6%); there were significant reductions in serum cortisol, fasting blood sugar, serum lipid, and C-reactive protein levels, as well.
Posted 16 March 2012 - 11:09 AM
Edited by dasheenster, 16 March 2012 - 11:11 AM.
Posted 16 March 2012 - 02:48 PM
Given that we don't really have an answer, I guess we can justify swapping anecdotes and making speculations for now.
Posted 21 March 2012 - 10:05 AM
Edited by Nooby, 21 March 2012 - 10:08 AM.
Posted 21 March 2012 - 03:48 PM
Posted 22 March 2012 - 12:41 AM
I agree with Nooby.
All these herbs are pretty weak and very rarely does anyone get withdrawals.
Posted 22 March 2012 - 06:08 AM
Posted 22 March 2012 - 06:46 PM
Tolerance on the other hand I have noticed with ashwagandha, valerian and theanine.
Edited by Deckah, 22 March 2012 - 06:47 PM.
Posted 22 March 2012 - 06:52 PM
Posted 23 March 2012 - 01:32 AM
Posted 01 June 2012 - 09:32 AM
Posted 26 June 2012 - 12:52 PM
Posted 26 June 2012 - 08:13 PM
I think it's BS! That ScienceGuy has a paranoid complex...
Edited by ScienceGuy, 26 June 2012 - 08:16 PM.
Posted 26 June 2012 - 08:38 PM
Posted 27 June 2012 - 09:11 AM
A good question was raised to you a few months ago ScienceGuy, which you however declined to answer. You were asked what you thought the optimal cycle frequency was, or put another way, how long one should use ashwagandha/valerian/related compounds and how long one should abstain from them before going back. If you let everything return all the way back to the baseline, what's the point of even using the drug?
Posted 27 June 2012 - 03:23 PM
Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects
Abstract
Objectives: To describe the pharmacokinetics of valerenic acid in a group of healthy adults after a single oral dose of valerian using a newly developed sensitive assay for serum concentrations of valerenic acid, a commonly used marker for qualitative and quantitative analysis of valerian root and valerian products.
Study design: Six healthy adults (22–61 years, five men, one female) received a single 600 mg dose of valerian at 08:00. Blood samples were collected for 8 h after administration. Valerenic acid was extracted from serum and measured using a LC/MS/MS method developed in our laboratory.
Results: The maximum serum concentration of valerenic acid for five of the six subjects occurred between 1 and 2 h ranging from 0.9 to 2.3 ng/mL. Valerenic acid serum concentrations were measurable for at least 5 h after the valerian dose. One subject showed a peak plasma value at 1 h and a second peak at 5 h. The elimination half-life (T1/2) for valerenic acid was 1.1 ± 0.6 h. The area under the concentration time curve (AUC) as a measure of valerenic acid exposure was variable (4.80 ± 2.96 µg/mL. h) and not correlated with subject's age or weight.
Conclusions: Assuming that valerenic acid serum concentrations correlate with the pharmacological activity of valerian, the timing of the valerenic acid peak concentration is consistent with the standard dosage recommendation to take valerian 30 min to 2 h before bedtime. Ongoing studies are evaluating the relationship between valerenic acid serum concentrations and objective measures of sleep in patients.
Edited by dasheenster, 27 June 2012 - 03:23 PM.
Posted 27 June 2012 - 06:39 PM
Well let's take a compound we roughly know the half life of. I know you discourage cannabis use since you believe it is anxiogenic long-term...
I would like to know if you have any reasons in support of the belief that it only matters that the GABA system should return to baseline, and other neurotransmitters/cellular mechanisms don't deserve attention...
I would also like to know from where you derive the estimated relxation period of 2 days.... I'm also naturally curious why you suggest a stress/disturbance/trigger period of 5 days...
Also, I'm not sure how you can say there is no information about the half lives of these compounds
(which you hate to call drugs, even though that's fundamentally what they are)
Edited by ScienceGuy, 27 June 2012 - 06:41 PM.
Posted 27 June 2012 - 08:04 PM
Seeing as CBD is overpriced, and it's nearly impossible to find cannabis high in CBD and low in THC, and seeing as we don't even totally understand CBD, I don't think many people take this suggestion of yours very seriously.Yes, but that's due to the THC; whereas PURE CANNABDIOL is a different matter entirely, and I encourage its medicinal use
I was not aware that it had been demonstrated that ashwagandha's primary mechanism of action was exhibited via GABA receptor agonism. I was aware of a study showing that ash at least activates GABA-A receptors in a dose-dependent manner, but I found nothing confirming that this is the PRIMARY mechanism of action.With regards to ASHWAGANDHA (which is the topic of this thread) the reason why it specifically matters that the GABA system should return to baseline, as opposed to other neurotransmitters/cellular mechanisms, is because ASHWAGANDHA's primary mechanism of action relating to its ANXIOLYTIC effect is specifically via AGONISM of the GABA RECEPTORS; and ASHWAGANDHA WITHDRAWAL occurs specifically as a consequence of down-regulation of the GABA RECEPTORS in the same way as BENZODIAZEPINE WITHDRAWAL occurs and that of all other GABA RECEPTOR AGONISTS, when taken for prolonged periods without breaks.
Well, I suppose at least it's an honest guess. But to clarify, this criteria appears distinct from "letting GABA system return to baseline", since we might be able to avoid a profound tolerance while still not letting equilibrium return completely. Do you think if someone experiences rebound anxiety after discontinuing ashwagandha that it's an indicator of overuse/abuse?Please do not misunderstand my suggestion of starting with a 5 DAYS ON, 2 DAYS OFF regimen. I am NOT stating that this is the ideal 'ON' and 'OFF' duration.
Since the half-life of the respective PHYTOCHEMICAL(S) contained within ASHWAGANDHA are at the present time unknown there is no way of properly confirming what is the ideal 'ON' and 'OFF' duration. So, in the spirit of trying to be helpful, what I have suggested is a process by which you can ascertain an appropriate 'ON' and 'OFF' duration and regimen which will prevent the manifestation of TOLERANCE, and consequently WITHDRAWAL, from occurring; wherein the 5 DAYS ON, 2 DAYS OFF is the suggested starting duration; and should be adjusted according to how you respond. I.e. If you find yourself starting to experience some TOLERANCE you should extend the duration of the OFF period, and so on until you find the 'sweet spot' wherein TOLERANCE is prevented.![]()
Please kindly note that this is a suggestion. You do not have to follow my advice.
We know the half-life of WFA in mice, at the least:With regards to ASHWAGANDHA (which is the topic of this thread), as I have stated above, unfortunately the half-life of the respective PHYTOCHEMICAL(S) contained within ASHWAGANDHA are indeed at the present time unknown.
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.
Abstract
Withaferin A (WFA) is purified from the plant Withania somnifera and inhibits the vimentin cytoskeleton. Vimentin overexpression in cancer correlates with metastatic disease, induction of epithelial to mesenchymal transition and reduced patient survival. As vimentin functions in cell motility, we wanted to test the hypothesis that WFA inhibits cancer metastasis by disrupting vimentin function. These data showed that WFA had weak cytotoxic and apoptotic activity at concentrations less than or equal to 500 nM, but retained potent anti-invasive activity at these low doses. Imaging of breast cancer cell lines revealed that WFA induces perinuclear vimentin accumulation followed by rapid vimentin depolymerization. A concomitant induction of vimentin ser56 phosphorylation was observed, which is consistent with vimentin disassembly. Structure activity relationships were established using a set of chemically modified WFA analogs and showed that the predicted vimentin-binding region of WFA is necessary to induce vimentin ser56 phosphorylation and for its anti-invasive activity. Pharmacokinetic studies in mice revealed that WFA reaches peak concentrations up to 2 μM in plasma with a half-life of 1.36 hr following a single 4 mg/kg dose. In a breast cancer metastasis mouse model, WFA showed dose-dependent inhibition of metastatic lung nodules and induced vimentin ser56 phosphorylation, with minimal toxicity to lung tissue. Based upon these studies, we conclude that WFA is a potent breast cancer anti-metastatic agent and the anti-metastatic activity of WFA is, at least in part, mediated through its effects on vimentin and vimentin ser56 phosphorylation.
I don't care too much to go into intricate details, but herbal extracts are nothing but collections of many naturally occurring drugs,having a few drugs highly concentrated through extraction/distillation. That's right, I label fructose as a drug, just as artificially produced drugs. Of course, I don't judge its merit based on its label, that I judge based on its apparent efficacy.Erm... sorry, but no they are not. DRUGS are DRUGS, HERBAL EXTRACTS are HERBAL EXTRACTS.... by definition HERBAL EXTRACTS are not DRUGS... but hey, if you want to call APPLES 'ORANGES' go right ahead; it won't make it so.
![]()
And BTW I happen to advocate usage of both; and yet favour neither. I believe that the benefits and therapeutics usage of a particular substance should be measured according to its own merit and not according to its label
Posted 28 June 2012 - 03:53 PM
Seeing as CBD is overpriced, and it's nearly impossible to find cannabis high in CBD and low in THC, and seeing as we don't even totally understand CBD, I don't think many people take this suggestion of yours very seriously.Yes, but that's due to the THC; whereas PURE CANNABDIOL is a different matter entirely, and I encourage its medicinal use
I was not aware that it had been demonstrated that ashwagandha's primary mechanism of action was exhibited via GABA receptor agonism. I was aware of a study showing that ash at least activates GABA-A receptors in a dose-dependent manner, but I found nothing confirming that this is the PRIMARY mechanism of action.
Do you think if someone experiences rebound anxiety after discontinuing ashwagandha that it's an indicator of overuse/abuse?
We know the half-life of WFA in mice, at the least...
...herbal extracts are nothing but collections of many naturally occurring drugs...
That's right, I label fructose as a drug, just as artificially produced drugs.
Of course, I don't judge its merit based on its label, that I judge based on its apparent efficacy.
Edited by ScienceGuy, 28 June 2012 - 04:00 PM.
Posted 28 June 2012 - 07:48 PM
It is true I brought up cannabis in the context of half-life, but I made no such recommendation to encourage (or discourage) the use of CBD, and/or CBD-rich and THC-less strains. I have chosen to remain mute, as I do not think the pharmacology is conclusive enough to provide practical and sound advise to those seeking a rush from drugs. Even though of all cannabinoids, CBD presently appears to me to have the greatest potential, I still think it suffers an undesirable profile of effects, which ultimately renders it unsafe and ineffective for any medical purposes. It acts as an agonist to 5-HT1A receptors (antidepressant, kind of like shrooms, which are thought to mediate their most pronounced effects through 5-HT2A agonism). It also allosterically modulates mu- and delta-opioid receptors (http://www.ncbi.nlm....pubmed/16489449). There is also a cytotoxic mechanism to CBD (http://www.ncbi.nlm....pubmed/20645411), which we have barely noticed, let alone realize or grasp or understand. These unfavorable aspects might balance out with the "anti-psychosis, anxiolytic, anti-depersonalization" effects which many people think CBD offers; see this study how it improves and worsens ketamine inducted psychopathology (http://www.ncbi.nlm....pubmed/21062637). There's no telling how these mechanisms would exhibit themselves in a long-term clinical setting, but my intuition says steer clear.What suggestion??? Please kindly note that it is in fact you who brought up the subject of CANNABIS, not I...
These do not prove it is its primary mechanism, through which it mediates the vast majority of its effects. It merely suffices to prove it is a mechanism, perhaps secondary or even tertiary. Even though ashwagandha was associated with reduced tribulin (http://www.ncbi.nlm....pubmed/11194174), that still doesn't vindicate your claim. I could just as easily say that caffeine is associated with increased dopamine, and therefore all its subtle improvements conferred to ADHD patients is due to its pro-dopaminergic activity. You can't predict how a drug is affecting the body just based on how it influences one factor...unless that factor reveals an exceptional amount of information about the biological state...which most factors don't So unless you've based your judgement on papers you're concealing from me, it seems to me that parading around these forums, dogmatically contending ashwagandha is primarily a GABAergic is therefore dishonest, premature, and perhaps misleading. You may derive pleasure from misinforming and corrupting people, but this kind of practice is discordant with my desire for humanity to flourish, and I shall therefore attempt to avoid it.OK, not a problem; here's some published studies for you which indicate ASHWAGANDHA's primary mechanism of action relating to its ANXIOLYTIC effect is specifically via AGONISM of the GABA RECEPTORS (and as it happens not just GABA-A):
While we cannot make a very accurate or precise prediction, pharmacology tells us the half life in humans is usually longer, or the half-life multiplier in translating from mice to human metabolism is usually greater than one, since the rate of excretion of metabolites per unit of body weight tends to become greater as the animal becomes smaller, and vice versa. In accordance with this principle, I might guess that ashwagandha has a half-life between 2-6 hours, though this is admittedly just a guess, and not even a very good one. I should not wish to issue this as a suggestion, but seeing as you're willing to issue suggestions, I'd like to know how your suggestion of 5/2 days would change if the half-life were to change. Supposing the half-life were actually half or double what you presently suppose it is, how would that affect your 5/2 recommendation at all? For something like cannabis, someone seeking an intermediate between complete addiction and complete abstinence might use it nightly for a week, then abstain for 3 days and nights before resuming. This 10 day cycle means ashwagandha must also have a long half life, as 5+2=7 is not much less than 10, or there must be highly nonlinear relationships between the half life and the ideal relaxation frequency/duration, such that a compound with a half life of 1/2 hour ought to be used for 4 days on then 1 day off, while a compound with a 2 hour half life ought to be used 5 days on 2 off, and a compound with a half life of 8 hours ought to be used 7 days on 3 days off. I think you get what I mean by nonlinear. As there is little research on this subject, my recommendations should be taken as a grain of salt, not some immutable truth; there is still much thinking needed to be done before we are to know the answers to these questions with regard to what constitutes ideal cycling.Yes, however unfortunately that is not especially useful when it comes to HUMANS
Depending on the connotation and context, a drug could be anything from a man-made chemical to a psychoactive constituent of a plant. Oxford has this: "A substance that has a physiological effect when ingested or otherwise introduced into the body, in particular." So by this definition, fructose is a drug, so is cellulose, and so is every compound, which, in connexion, constitute the totality of the plant. The plant is nothing but a set of chemicals, so too is the extract of the plant. Strictly speaking, it's an error to say a plant is a drug, but depending on how you frame the meaning of "drug", it could be correct to say all plants are just bunches of drugs, mild to potent, physical or psychoactive, but nevertheless drugs which humans could theoretically produce in the lab, in isolation, and which would theoretically have the same effect, excusing any interactions which occur in the plant.I know where you are coming from with regards to viewing matters that way; however, you are not correct in referring to herbal extracts as drugs, and furthermore there are very serious potential ramifications for doing so that might cause you to re-think your perspective.
Firstly, take WHITE WILLOW BARK for example; this is not a drug. However, ASPIRIN is. Another example is EPHEDRA; this also is not a drug. However, EPHEDRINE is. Do you understand the difference?
Secondly, all drugs must have a medicinal license; they cannot legally be sold without one. Whereas, herbal extracts are classified as supplements and do not require a medicinal license to be sold. If herbal extracts are classified as drugs then they would require a medicinal license to be sold, wherein due to the cost involved essentially this would mean an end to legal resale of most herbal extracts... is that what you want to happen? Assuming that you do not, I strongly urge you to re-think your perspective on whether or not herbal extracts are drugs.
FRUCTOSE by definition is not a drug either; and it's a bad example anyway, because the vast majority of FRUCTOSE is in fact "artificially produced"
You need to read the following:
Definition of DRUG
1 a : a substance used as a medication or in the preparation of medication
b: according to the Food, Drug, and Cosmetic Act (1) : a substance recognized in an official pharmacopoeia or formulary (2) : a substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease (3) : a substance other than food intended to affect the structure or function of the body (4) : a substance intended for use as a component of a medicine but not a device or a component, part, or accessory of a device
Good to hear! There's too many people who pay too much attention to a substance's classification as opposed to its actual PHYSIOLOGICAL / PHARMACOLOGICAL effects
Edited by dasheenster, 28 June 2012 - 08:12 PM.
Posted 28 June 2012 - 08:34 PM
...it seems to me that parading around these forums, dogmatically contending ashwagandha is primarily a GABAergic is therefore dishonest, premature, and perhaps misleading. You may derive pleasure from misinforming and corrupting people, but this kind of practice is discordant...
I suppose only dwelling in idiot circles would accustom oneself to believing there are disproportionately more people who hold ridiculous opinions than who hold reasonable ones...
Edited by ScienceGuy, 28 June 2012 - 08:35 PM.
Posted 29 June 2012 - 02:53 PM
Edited by dasheenster, 29 June 2012 - 02:59 PM.
Science & Health →
Brain Health →
Mental Health →
5-HT1A - PSSD/ANHEDONIA From AshwagandhaStarted by ErgogenicHealth , 02 Feb 2021 ![]() |
|
![]()
|
||
Science & Health →
Supplements →
Cytotoxicity of Withaferin-A?Started by adastra , 22 Aug 2020 ![]() |
|
![]()
|
||
Science & Health →
Brain Health →
Mental Health →
Antidepressants and gaba, ashwagandha, L-theanineStarted by jazzyt , 02 Mar 2020 ![]() |
|
![]()
|
||
Science & Health →
Supplements →
ashwagandha side effects?Started by faxmulder , 28 Jan 2020 ![]() |
|
![]()
|
||
Science & Health →
Supplements →
Ashwagandha side effectsStarted by faxmulder , 14 Jun 2019 ![]() |
|
![]()
|
0 members, 1 guests, 0 anonymous users